MCK
Mckesson CorporationHealth Careinsider_universeEverything we've seen
- ?Sep 2, 2:40 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MCK is up 1.82% today with 65 minutes remaining — a meaningful move but not outsized for this name. No headlines explain the move, suggesting institutional flow rather than a news catalyst, which can sustain or reverse unpredictably. The macro context shows T5YIFR elevated at 1.7σ above trend, indicating rate-sensitive sectors face a mild headwind; MCK as a healthcare distributor is not highly rate-sensitive, so this is a modest negative but not disqualifying. With only 65 minutes to close, there is limited runway to hit the +3% target from current levels (would require an additional ~1.18% gain). The move is real and represents conviction, but the combination of no catalyst, mildly unfavorable rate environment for risk assets broadly, and limited time remaining keeps this a borderline call. No reversal signals are evident, so momentum bias tilts marginally toward continuation. Probability set just above the 0.5 threshold reflecting genuine uncertainty without a clear fade signal.
- !Sep 2, 2:40 PMsignalseverity 0.02
Agent 7 — Day Trader — day_trade_skipped
MCK is up 1.82% today with 65 minutes remaining — a meaningful move but not outsized for this name. No headlines explain the move, suggesting institutional flow rather than a news catalyst, which can sustain or reverse unpredictably. The macro context shows T5YIFR elevated at 1.7σ above trend, indicating rate-sensitive sectors face a mild headwind; MCK as a healthcare distributor is not highly rate-sensitive, so this is a modest negative but not disqualifying. With only 65 minutes to close, there is limited runway to hit the +3% target from current levels (would require an additional ~1.18% gain). The move is real and represents conviction, but the combination of no catalyst, mildly unfavorable rate environment for risk assets broadly, and limited time remaining keeps this a borderline call. No reversal signals are evident, so momentum bias tilts marginally toward continuation. Probability set just above the 0.5 threshold reflecting genuine uncertainty without a clear fade signal.
- ?Sep 2, 10:40 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MCK is up 1.55% today with no attributable headline, suggesting quiet institutional accumulation or sector rotation rather than a news-driven spike that might fade. The move is modest (sub-2%), not extended enough to trigger mean-reversion concern. With 305 minutes remaining there is ample time for continuation into the close. The macro context shows 5-year forward inflation expectations elevated at 1.7σ above trend, which modestly pressures rate-sensitive sectors, but MCK (healthcare distribution/managed care-adjacent) has low direct rate sensitivity and is not a primary beneficiary or victim of that dynamic. No reversal pattern or news catalyst to fade is evident. The setup is ordinary positive momentum with no strong reason to reverse — slight lean toward continuation but no high-conviction signal.
- !Sep 2, 10:40 AMsignalseverity 0.02
Agent 7 — Day Trader — day_trade_skipped
MCK is up 1.55% today with no attributable headline, suggesting quiet institutional accumulation or sector rotation rather than a news-driven spike that might fade. The move is modest (sub-2%), not extended enough to trigger mean-reversion concern. With 305 minutes remaining there is ample time for continuation into the close. The macro context shows 5-year forward inflation expectations elevated at 1.7σ above trend, which modestly pressures rate-sensitive sectors, but MCK (healthcare distribution/managed care-adjacent) has low direct rate sensitivity and is not a primary beneficiary or victim of that dynamic. No reversal pattern or news catalyst to fade is evident. The setup is ordinary positive momentum with no strong reason to reverse — slight lean toward continuation but no high-conviction signal.
- ?Sep 1, 12:45 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MCK is up 2.36% with 180 minutes remaining — a meaningful intraday move with real flow behind it and ample time to extend. No headlines are present, which is neutral rather than negative; large moves in MCK (a healthcare distribution mega-cap) often reflect institutional rebalancing or sector rotation rather than single news catalysts. The macro context (elevated 2Y yields at 2σ above trend) is modestly unfavorable for rate-sensitive sectors but MCK is a defensive healthcare name with relatively low duration sensitivity and tends to be insulated from rate pressure. No reversal signals are evident — the move is directional from open without a described fade off highs. With 3 hours remaining, there is sufficient session time for continuation. However, the absence of a clear catalyst limits conviction above the baseline, and elevated short-term rates could weigh on broader risk appetite into the close. Assigning a moderate continuation probability consistent with ordinary momentum in the absence of a strong counter-thesis.
- !Sep 1, 12:45 PMsignalseverity 0.02
Agent 7 — Day Trader — day_trade_skipped
MCK is up 2.36% with 180 minutes remaining — a meaningful intraday move with real flow behind it and ample time to extend. No headlines are present, which is neutral rather than negative; large moves in MCK (a healthcare distribution mega-cap) often reflect institutional rebalancing or sector rotation rather than single news catalysts. The macro context (elevated 2Y yields at 2σ above trend) is modestly unfavorable for rate-sensitive sectors but MCK is a defensive healthcare name with relatively low duration sensitivity and tends to be insulated from rate pressure. No reversal signals are evident — the move is directional from open without a described fade off highs. With 3 hours remaining, there is sufficient session time for continuation. However, the absence of a clear catalyst limits conviction above the baseline, and elevated short-term rates could weigh on broader risk appetite into the close. Assigning a moderate continuation probability consistent with ordinary momentum in the absence of a strong counter-thesis.
- ?Sep 1, 10:40 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MCK is up 2.28% today with no headline catalyst identified, suggesting this is flow/positioning-driven rather than news-driven. At 305 minutes remaining (roughly 5+ hours), there is ample time for continuation. MCK is a defensive healthcare distributor — largely insensitive to the elevated 2yr yield (4.34, +2σ) macro context that primarily pressures banks and long-duration tech. The absence of a news driver is not disqualifying per methodology; the move itself represents meaningful conviction from size participants. However, without a clear catalyst or confirmation of sustained volume, and given the move is already 2.28% off the prior close (approaching the lower bound of the 2-5% 'meaningful' range), there is some risk of a midday fade or consolidation. No reversal signals are evident. Net assessment: modest upside continuation bias with no strong reason to expect fade, but no high-conviction setup either. Probability set at 0.54 — slightly above threshold reflecting ordinary momentum in a macro-insensitive sector with time remaining.
- !Sep 1, 10:40 AMsignalseverity 0.02
Agent 7 — Day Trader — day_trade_skipped
MCK is up 2.28% today with no headline catalyst identified, suggesting this is flow/positioning-driven rather than news-driven. At 305 minutes remaining (roughly 5+ hours), there is ample time for continuation. MCK is a defensive healthcare distributor — largely insensitive to the elevated 2yr yield (4.34, +2σ) macro context that primarily pressures banks and long-duration tech. The absence of a news driver is not disqualifying per methodology; the move itself represents meaningful conviction from size participants. However, without a clear catalyst or confirmation of sustained volume, and given the move is already 2.28% off the prior close (approaching the lower bound of the 2-5% 'meaningful' range), there is some risk of a midday fade or consolidation. No reversal signals are evident. Net assessment: modest upside continuation bias with no strong reason to expect fade, but no high-conviction setup either. Probability set at 0.54 — slightly above threshold reflecting ordinary momentum in a macro-insensitive sector with time remaining.
- ?Aug 25, 2:50 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MCK is up 2.82% today with no attributed headline, suggesting institutional flow or a sector rotation into defensive/healthcare names. The move is meaningful in magnitude and likely driven by real conviction. However, with only 55 minutes remaining until the forced close, there is limited runway for the +3% profit target to be reached from current levels (would require another ~0.18% from here, which is achievable but tight). The macro context shows 5Y forward inflation expectations elevated at 1.8σ above trend — rate-sensitive sectors face some headwind, but MCK as a healthcare distributor is not a primary rate-sensitive name and may be benefiting from a defensive rotation in a higher-inflation regime. No news to catalysol a reversal, and no fade signal is evident. With no reversal pattern flagged and the move already near the profit target threshold, this is a borderline continuation setup. Probability slightly above 0.5 given modest time remaining and no adverse catalysts, but not a high-conviction setup warranting 0.7+.
- !Aug 25, 2:50 PMsignalseverity 0.03
Agent 7 — Day Trader — day_trade_skipped
MCK is up 2.82% today with no attributed headline, suggesting institutional flow or a sector rotation into defensive/healthcare names. The move is meaningful in magnitude and likely driven by real conviction. However, with only 55 minutes remaining until the forced close, there is limited runway for the +3% profit target to be reached from current levels (would require another ~0.18% from here, which is achievable but tight). The macro context shows 5Y forward inflation expectations elevated at 1.8σ above trend — rate-sensitive sectors face some headwind, but MCK as a healthcare distributor is not a primary rate-sensitive name and may be benefiting from a defensive rotation in a higher-inflation regime. No news to catalysol a reversal, and no fade signal is evident. With no reversal pattern flagged and the move already near the profit target threshold, this is a borderline continuation setup. Probability slightly above 0.5 given modest time remaining and no adverse catalysts, but not a high-conviction setup warranting 0.7+.
- ?Aug 25, 1:10 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MCK is up 1.82% today with ~155 minutes remaining — a moderate move with reasonable time left. No news headlines are available to explain the move, but per guidance, absence of news does not disqualify continuation. The macro context (5Y5Y forward inflation 1.8σ above trend) is modestly negative for rate-sensitive sectors, but MCK as a healthcare distribution company has relatively low direct rate sensitivity compared to REITs or utilities. The 1.82% move is meaningful but sits at the lower bound of the 'significant flow' range, suggesting some conviction but not a blowout. With no reversal signals, no fade pattern mentioned, and ample time remaining, the base case is modest continuation. However, without a clear catalyst or strong sector tailwind, and with slightly elevated inflation expectations that could weigh on risk appetite broadly into the close, this is a borderline read. Assigning a slim continuation edge above 0.5 in the absence of countervailing evidence.
- !Aug 25, 1:10 PMsignalseverity 0.02
Agent 7 — Day Trader — day_trade_skipped
MCK is up 1.82% today with ~155 minutes remaining — a moderate move with reasonable time left. No news headlines are available to explain the move, but per guidance, absence of news does not disqualify continuation. The macro context (5Y5Y forward inflation 1.8σ above trend) is modestly negative for rate-sensitive sectors, but MCK as a healthcare distribution company has relatively low direct rate sensitivity compared to REITs or utilities. The 1.82% move is meaningful but sits at the lower bound of the 'significant flow' range, suggesting some conviction but not a blowout. With no reversal signals, no fade pattern mentioned, and ample time remaining, the base case is modest continuation. However, without a clear catalyst or strong sector tailwind, and with slightly elevated inflation expectations that could weigh on risk appetite broadly into the close, this is a borderline read. Assigning a slim continuation edge above 0.5 in the absence of countervailing evidence.
- ?Aug 24, 11:46 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MCK is up 1.60% with ~239 minutes remaining, a moderate move without a clear news catalyst. This is below the 2-5% threshold where momentum is most compelling, but still represents meaningful upside flow. No headlines suggest a reversal catalyst. The macro context shows 5Y5Y inflation expectations elevated (~1.6σ above trend), which is modestly unfavorable for rate-sensitive sectors broadly, but MCK as a healthcare distributor is not particularly rate-sensitive and should not be directly impaired. Absence of news is not disqualifying per the framework. With nearly 4 hours remaining, there is ample time for continuation. The move is not extreme enough to flag exhaustion or overextension. No reversal pattern or volume concern is evident from available data. Overall this reads as ordinary momentum with no strong reason to fade — probability set just above the 0.5 threshold.
- !Aug 24, 11:46 AMsignalseverity 0.02
Agent 7 — Day Trader — day_trade_skipped
MCK is up 1.60% with ~239 minutes remaining, a moderate move without a clear news catalyst. This is below the 2-5% threshold where momentum is most compelling, but still represents meaningful upside flow. No headlines suggest a reversal catalyst. The macro context shows 5Y5Y inflation expectations elevated (~1.6σ above trend), which is modestly unfavorable for rate-sensitive sectors broadly, but MCK as a healthcare distributor is not particularly rate-sensitive and should not be directly impaired. Absence of news is not disqualifying per the framework. With nearly 4 hours remaining, there is ample time for continuation. The move is not extreme enough to flag exhaustion or overextension. No reversal pattern or volume concern is evident from available data. Overall this reads as ordinary momentum with no strong reason to fade — probability set just above the 0.5 threshold.
- ?Aug 10, 6:04 PMdecisionconsidered
Agent 20 — SIR Price/Volume — skip
[distribution] The 20-day PV path tells a clear distributional story. The sharp up-day on 2026-07-28 ($889.50, 1.6M — the single largest volume session in the window) marked the price apex, but that high-volume surge was immediately followed by five consecutive down-days (Jul 29–Aug 3) on sustained above-average volume (838K–1.4M vs. 998K ADV), pulling price from $888.56 all the way back to $827.14 — a classic "buy the news, sell into strength" distribution signature. The most recent three sessions (Aug 5–Aug 7) show a brief reflexive bounce to $877.23 on 1.1M, immediately reversed on Aug 6 (−0.67%, 1.6M) and Aug 7 (−0.21%, 1.6M): net negative price movement on the heaviest volume of the sub-period, confirming sellers are re-emerging at the highs. The overall 20-day path drifts down-and-right from the Jul-28 peak, with down-day volume consistently meeting or exceeding up-day volume since that climax bar. Risks: A decisive reclaim of the $889–$890 level on volume materially above 1.6M (the current supply ceiling) would invalidate the distributional read and reopen the bullish case. Additionally, the macro context (5Y inflation expectations 1.6σ below trend) primarily favors Gold/Energy/TIPS rather than Health Care, so an unexpected sector rotation into defensive Health Care names could lift MCK independently of its PV structure.
- ?Aug 5, 10:06 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MCK is up ~2.93% intraday, which represents meaningful institutional flow and conviction. No news headlines are present, but per guidance, absence of news is not disqualifying — large moves often occur on institutional rebalancing, sector rotation, or positioning ahead of known catalysts. The macro context (5Y breakeven inflation at 1.9σ below trend) is modestly favorable for defensive/healthcare names like MCK, as low inflation expectations tend to support growth-oriented multiples and reduce cost-pressure fears for healthcare distributors. With 340 minutes remaining (session just past midpoint), there is ample time for continuation. However, the lack of a clear catalyst and no volume signal to assess creates uncertainty. The move is meaningful but not extreme (under 3%), and without a news driver or clear sector tailwind specific to MCK, this reads as ordinary momentum. Positioning modestly long with the expectation that intraday momentum and the supportive macro backdrop (low inflation = less margin pressure for distributors) allow partial continuation into the close, but not a high-conviction setup.
- !Aug 5, 10:06 AMsignalseverity 0.03
Agent 7 — Day Trader — day_trade_skipped
MCK is up ~2.93% intraday, which represents meaningful institutional flow and conviction. No news headlines are present, but per guidance, absence of news is not disqualifying — large moves often occur on institutional rebalancing, sector rotation, or positioning ahead of known catalysts. The macro context (5Y breakeven inflation at 1.9σ below trend) is modestly favorable for defensive/healthcare names like MCK, as low inflation expectations tend to support growth-oriented multiples and reduce cost-pressure fears for healthcare distributors. With 340 minutes remaining (session just past midpoint), there is ample time for continuation. However, the lack of a clear catalyst and no volume signal to assess creates uncertainty. The move is meaningful but not extreme (under 3%), and without a news driver or clear sector tailwind specific to MCK, this reads as ordinary momentum. Positioning modestly long with the expectation that intraday momentum and the supportive macro backdrop (low inflation = less margin pressure for distributors) allow partial continuation into the close, but not a high-conviction setup.
- ?Jul 30, 10:41 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MCK is down 2.17% with no attributable headline, suggesting institutional selling or sector rotation rather than a news-driven panic that might quickly reverse. The macro context (5Y inflation expectations 1.5σ below trend) is modestly deflationary, which is neutral-to-slightly-negative for healthcare distributors like MCK as it implies softer pricing power broadly, though MCK is not a primary sector reactor to TIPS/inflation signals. With 305 minutes remaining there is ample time for continuation, but also ample time for a mean-reversion bounce. The absence of news cuts both ways — no catalyst to drive further aggressive selling, but also no catalyst to spark a reversal. The move is meaningful (>2%) and likely reflects real institutional flow, which statistically tends to persist intraday more often than not. No reversal pattern is evident from the data provided. Overall, slight lean toward continuation down given the magnitude and real-flow inference, but conviction is modest — probability just above the 0.5 threshold.
- !Jul 30, 10:41 AMsignalseverity -0.02
Agent 7 — Day Trader — day_trade_skipped
MCK is down 2.17% with no attributable headline, suggesting institutional selling or sector rotation rather than a news-driven panic that might quickly reverse. The macro context (5Y inflation expectations 1.5σ below trend) is modestly deflationary, which is neutral-to-slightly-negative for healthcare distributors like MCK as it implies softer pricing power broadly, though MCK is not a primary sector reactor to TIPS/inflation signals. With 305 minutes remaining there is ample time for continuation, but also ample time for a mean-reversion bounce. The absence of news cuts both ways — no catalyst to drive further aggressive selling, but also no catalyst to spark a reversal. The move is meaningful (>2%) and likely reflects real institutional flow, which statistically tends to persist intraday more often than not. No reversal pattern is evident from the data provided. Overall, slight lean toward continuation down given the magnitude and real-flow inference, but conviction is modest — probability just above the 0.5 threshold.
- ?Jul 29, 12:00 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MCK is up 1.67% today with no headline catalyst visible, suggesting this is flow/momentum driven rather than news-driven. The move is meaningful but not extreme (below the 2-5% high-conviction threshold). Macro context shows 10Y inflation expectations (T10YIE) printing 1.8σ below trend, which is broadly supportive of defensively-oriented, low-duration-sensitivity sectors like healthcare distribution — MCK is a healthcare distributor and would not be particularly hurt by low inflation expectations. With 225 minutes remaining there is ample time for continuation. No reversal signals or fade patterns are evident from the data provided. No news absence penalty applies per instructions. The setup is ordinary momentum with a mildly supportive macro backdrop, warranting a modest continuation probability above 0.5 but not enough evidence for high conviction.
- !Jul 29, 12:00 PMsignalseverity 0.02
Agent 7 — Day Trader — day_trade_skipped
MCK is up 1.67% today with no headline catalyst visible, suggesting this is flow/momentum driven rather than news-driven. The move is meaningful but not extreme (below the 2-5% high-conviction threshold). Macro context shows 10Y inflation expectations (T10YIE) printing 1.8σ below trend, which is broadly supportive of defensively-oriented, low-duration-sensitivity sectors like healthcare distribution — MCK is a healthcare distributor and would not be particularly hurt by low inflation expectations. With 225 minutes remaining there is ample time for continuation. No reversal signals or fade patterns are evident from the data provided. No news absence penalty applies per instructions. The setup is ordinary momentum with a mildly supportive macro backdrop, warranting a modest continuation probability above 0.5 but not enough evidence for high conviction.
- ❖Jul 28, 12:57 PMnewsvia finnhub
Ecolab Q2 Earnings & Revenues Beat Estimates, Stock Up in Pre-Market
ECL stock rises pre-market after earnings and revenues beat estimates, as pricing, volume growth and core-business demand lift organic sales.
- ❖Jul 28, 12:55 PMnewsvia finnhub
OPKO Health Stock Up as Q2 Earnings & Revenues Beat Estimates
OPK beats Q2 estimates as pharmaceutical growth, Nicoya income and lower costs narrow losses and lift shares pre-market.
- ▣Jul 27, 8:00 PMjournaltarget
Agent 4 — Dip Buyer (Frozen) closed long 1 @ $889.86 (+$113.89)
Target hit: close $889.86 ≥ target $879.10
- ❖Jul 27, 9:54 AMnewsvia finnhub
The Buyback Machine Hiding Behind Cardinal Health's Thin Margins
A steadily shrinking share count and a giant float owed to suppliers are handing owners a bigger slice of the drug distributor each year, even as drug-pricing worries hang over the stock.
- ❖Jul 27, 9:30 AMnewsvia finnhub
Is McKesson (MCK) a Buy as Wall Street Analysts Look Optimistic?
According to the average brokerage recommendation (ABR), one should invest in McKesson (MCK). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
- ❖Jul 27, 9:24 AMnewsvia finnhub
MMED Gets Medicare Coverage for Flex and Broadens Diabetes Care Access
MiniMed expands Flex access to Medicare beneficiaries, widening availability of its app-controlled pump and automated insulin delivery technology.
- ❖Jul 25, 7:08 PMnewsvia finnhub
McKesson (MCK) Declares Quarterly Dividend, Is The Stock Still Undervalued?
McKesson (MCK) has announced a quarterly dividend of $0.94 per share, payable on October 1, 2026. Both the ex dividend and record dates are set for September 1, 2026, drawing fresh attention to the stock. See our latest analysis for McKesson. At a latest share price of $840.90, McKesson has seen a 1 day share price return of 1.99% and a 1 month share price return of 9.70%, while its 1 year total shareholder return of 18.61% and 5 year total shareholder return of 323.86% indicate solid longer...
- ❖Jul 25, 7:10 AMnewsvia finnhub
McKesson (MCK) Stock May Still Be A Bargain After A 324% Run
McKesson stock has logged a very strong 323.9% return over the past five years, yet the latest valuation checks still flag it as screening on the cheap side. This raises the question of how much of the story is already reflected in the current US$840.90 share price. Over five years, McKesson has returned 323.9%, which puts long term holders in a strong position and makes today’s entry point more sensitive to the valuation starting point. For valuation, the key support is the company’s role...
- ❖Jul 25, 2:10 AMnewsvia finnhub
Rising Dividend and Buybacks Might Change The Case For Investing In McKesson (MCK)
Earlier this week, McKesson Corporation announced a quarterly dividend of US$0.94 per share, payable on October 1, 2026, to shareholders of record as of the September 1, 2026 ex-dividend and record date. This higher payout highlights how McKesson is combining dividend growth with its existing share repurchase efforts, reinforcing management’s confidence in the company’s earnings power. Against this backdrop of a higher quarterly dividend, we’ll now examine how the announcement interacts with...
- ❖Jul 24, 2:06 PMnewsvia finnhub
Dividend Champion, Contender, And Challenger Highlights: Week Of July 26
Get the weekly dividend update for Champions, Contenders & Challengersâread about the dividend changes, upcoming ex-dividend dates and pay dates here.
- ❖Jul 24, 11:21 AMnewsvia finnhub
Citigroup Maintains Buy on McKesson, Raises Price Target to $1000
Citigroup analyst Daniel Grosslight maintains McKesson (NYSE:MCK) with a Buy and raises the price target from $945 to $1000.
- ❖Jul 24, 11:09 AMnewsvia finnhub
Here's Why You Should Add Cencora Stock to Your Portfolio Now
COR's specialty expansion, supply-chain investments and international momentum support growth, though pricing, debt and regulation pose risks.
- ❖Jul 24, 11:05 AMnewsvia finnhub
Revvity Develops High-Throughput T-SPOT.TB Platform for Clinical Labs
RVTY's T-SPOT A201 targets a 2027 launch, promising high-throughput latent TB testing with greater lab efficiency and scalability.
- ❖Jul 23, 4:04 PMnewsvia finnhub
1 S&P 500 Stock on Our Buy List and 2 Facing Challenges
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.
- ❖Jul 23, 2:08 PMnewsvia finnhub
WST Stock Jumps on Q2 Earnings & Sales Beat, EPS View Up on HVP Growth
WST tops Q2 earnings and revenue estimates, lifts its 2026 EPS outlook and sees shares surge as high-value products fuel strong growth.
- ❖Jul 23, 6:45 AMnewsvia finnhub
RH Announces the Appointment of Ryan Hassanein as Chief Legal & Compliance Officer
CORTE MADERA, Calif., July 23, 2026--RH (NYSE: RH) announced today the appointment of Ryan Hassanein as Chief Legal & Compliance Officer.
- ❖Jul 22, 5:50 PMnewsvia finnhub
Here's Why McKesson (MCK) Fell More Than Broader Market
In the most recent trading session, McKesson (MCK) closed at $814.04, indicating a -1.79% shift from the previous trading day.
- ❖Jul 22, 9:00 AMnewsvia finnhub
Is Trending Stock McKesson Corporation (MCK) a Buy Now?
Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
- ❖Jul 22, 8:30 AMnewsvia finnhub
Here's How Much You'd Have If You Invested $1000 in McKesson a Decade Ago
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
- ❖Jul 22, 8:00 AMnewsvia finnhub
McKesson Corporation Raises Quarterly Dividend by 15% to $0.94 Per Share
IRVING, Texas, July 22, 2026--The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of $0.94 per share of common stock, a 15% increase from $0.82 per share in the prior quarter. The dividend will be payable on October 1, 2026, to shareholders of record on September 1, 2026.
- ❖Jul 22, 4:04 AMnewsvia finnhub
McKesson Raises Quarterly Dividend From $0.82 To $0.94 Per Share
The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of $0.94 per share of common stock, a 15% increase from $0.82 per share in the prior quarter. The dividend will be payable
- ❖Jul 21, 6:32 AMnewsvia finnhub
TD Cowen Maintains Buy on McKesson, Lowers Price Target to $989
TD Cowen analyst Charles Rhyee maintains McKesson (NYSE:MCK) with a Buy and lowers the price target from $1012 to $989.
- ❖Jul 21, 4:30 AMnewsvia finnhub
Earnings Season May Be Last Hurrah For Hyperscalers And A Turning Point In The Market Cycle
Q2 earnings could mark a market turning point as AI/growth risks rise and sentiment shifts to sector rotation. Click here to read what investors need to know.
- ❖Jul 20, 6:00 PMnewsvia finnhub
McKesson (MCK) Declines More Than Market: Some Information for Investors
McKesson (MCK) closed at $831.46 in the latest trading session, marking a -1.18% move from the prior day.
- ❖Jul 17, 6:54 AMnewsvia finnhub
McKesson's Q1 2027 Earnings: What to Expect
McKesson is expected to announce its second-quarter earnings next month, and Wall Street forecasts a double-digit rise in its profits.
- ❖Jul 16, 12:35 PMnewsvia finnhub
Exploring the top movers within the S&P500 index during today's session.
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Thursday.
- ❖Jul 16, 10:36 AMnewsvia finnhub
Here’s Why McKesson Corporation (MCK) Slid in Q2
Janus Henderson Investors, an investment management company, released its second-quarter 2026 investor letter for the “Global Sustainable Equity Fund”. A copy of the letter can be downloaded here. Global equities experienced a robust quarter, with the Fund returning 16.17%, outperforming the Index’s 13.16% gain and the Peer Group’s 12.98% return. An overweight in information technology, particularly AI […]
- ✓Jul 16, 10:15 AMdecisionacted
Agent 7 — Day Trader — decide: buy
MCK is up 2.83% today, a meaningful move reflecting real institutional flow. There is no MCK-specific headline driving an obvious catalyst, but absence of news is not disqualifying — large cap healthcare distributors like MCK can move on sector rotation, options activity, or earnings-related positioning. The macro context (5Y inflation breakevens 1.6σ below trend) is mildly supportive for defensive, non-cyclical names like MCK, as lower inflation expectations can compress discount rates and favor stable-cash-flow businesses. The irrelevant Cheniere headline provides no read on MCK. With 330 minutes remaining (essentially most of the trading day still ahead), there is ample time for continuation if momentum holds. The primary risks are: (1) no clear catalyst means the move could be supply-absorption rather than demand-driven, increasing fade risk; (2) a ~$22 move on a ~$800 stock is a large single-session move that may attract profit-taking into the close. Balancing the strong momentum signal against the lack of confirmed catalyst and potential for mean-reversion, a modest continuation probability is appropriate — not a high-conviction setup, but the asymmetric stop/target structure favors taking the trade.
- ❖Jul 16, 6:12 AMnewsvia finnhub
Cheniere Energy (LNG) Appoints Britt Vitalone As It Reworks Key Credit Lines
Cheniere Energy (NYSE:LNG) has appointed Britt Vitalone, a veteran finance leader with experience at McKesson and Align Technology, to its Board of Directors. Vitalone will serve on both the Audit and Compensation Committees, adding expertise in corporate finance, capital allocation, and governance. The company has also adjusted several revolving credit facilities, including higher commitments, extended maturities, and updated terms for subsidiary credit lines. These governance and credit...
- ▢Jul 15, 8:00 PMjournal
Agent 7 — Day Trader opened long 3 @ $818.92
- ▣Jul 15, 8:00 PMjournaltarget
Agent 7 — Day Trader closed long 3 @ $843.61 (+$74.09)
Long target: close $843.61 ≥ target $843.48
- ❖Jul 15, 3:26 AMnewsvia finnhub
2 Profitable Stocks Worth Investigating and 1 We Turn Down
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, “Your margin is my opportunity”.
- ❖Jul 14, 6:00 PMnewsvia finnhub
McKesson (MCK) Stock Dips While Market Gains: Key Facts
McKesson (MCK) closed at $803.37 in the latest trading session, marking a -1.1% move from the prior day.
- ❖Jul 14, 4:34 PMnewsvia finnhub
Cheniere Appoints Britt Vitalone to Board of Directors
HOUSTON, July 14, 2026--Cheniere Appoints Britt Vitalone to Board of Directors
- ❖Jul 14, 3:31 AMnewsvia finnhub
Zacks Industry Outlook McKesson, Cardinal, West Pharmaceutical, Align and Henry
McKesson, Cardinal, West Pharmaceutical, Align and Henry have been highlighted in this Industry Outlook article.
- ❖Jul 13, 12:36 PMnewsvia finnhub
5 Medical Supply Stocks to Buy Amid Strong Industry Tailwinds
Here, we highlight five dental supplies stocks, MCK, CAH, WST, ALGN and HSIC, which are well positioned to generate wealth for investors amid improving industry prospect.
- ?Jul 13, 9:50 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MCK is up 1.67% today, a moderate but meaningful intraday move suggesting real buying flow. There are no headlines to explain the move, but absence of news is not disqualifying — this could be sector rotation into defensive/healthcare names, which is consistent with the macro context: the T10Y2Y spread is 2.1σ below trend, indicating a flattening/near-inverted curve environment that historically benefits defensives. MCK as a large-cap healthcare distributor fits the defensive rotation thesis well. With 355 minutes remaining (essentially the full afternoon session), there is ample time for continuation. No reversal signals are evident from the data provided. The move is below the 2-5% 'high conviction' threshold, so this is an ordinary momentum read rather than a strong breakout. No macro headwinds specific to MCK's business are flagged. Assigning a modest continuation probability above the threshold — the defensive sector tailwind from the curve context provides a marginal supporting factor, but the moderate move magnitude and lack of a specific catalyst keep confidence in the ordinary range.
- !Jul 13, 9:50 AMsignalseverity 0.02
Agent 7 — Day Trader — day_trade_skipped
MCK is up 1.67% today, a moderate but meaningful intraday move suggesting real buying flow. There are no headlines to explain the move, but absence of news is not disqualifying — this could be sector rotation into defensive/healthcare names, which is consistent with the macro context: the T10Y2Y spread is 2.1σ below trend, indicating a flattening/near-inverted curve environment that historically benefits defensives. MCK as a large-cap healthcare distributor fits the defensive rotation thesis well. With 355 minutes remaining (essentially the full afternoon session), there is ample time for continuation. No reversal signals are evident from the data provided. The move is below the 2-5% 'high conviction' threshold, so this is an ordinary momentum read rather than a strong breakout. No macro headwinds specific to MCK's business are flagged. Assigning a modest continuation probability above the threshold — the defensive sector tailwind from the curve context provides a marginal supporting factor, but the moderate move magnitude and lack of a specific catalyst keep confidence in the ordinary range.
- ❖Jul 13, 8:00 AMnewsvia finnhub
McKesson Releases Fiscal Year 2026 Impact Report
IRVING, Texas, July 13, 2026--McKesson published its Fiscal Year 2026 Impact Report, capturing how the company is actively turning purpose into action across healthcare.
- ❖Jul 11, 1:06 PMnewsvia finnhub
McKesson (MCK) Falls After CEO Share Sale, Is The 14% Discount Enough?
McKesson (MCK) is back in focus after a 3.5% share decline following CEO Brian S. Tyler’s sale of 8,463 shares, worth about US$6.7 million, under a pre arranged trading plan. See our latest analysis for McKesson. That reaction sits against a mixed backdrop for McKesson, with the share price returning 2.5% over seven days but declining 6.9% over three months, while the 1 year total shareholder return of 14.0% and very large 5 year total shareholder return indicate that longer term momentum...
- ❖Jul 11, 5:10 AMnewsvia finnhub
Can McKesson (MCK) Stay Cheap After A 338% Five Year Run?
McKesson stock has delivered a very large 337.6% total return over the past 5 years, yet the latest valuation checks still suggest the shares lean cheap rather than stretched after that run. Over 5 years, McKesson’s 337.6% return points to a stock that has already rewarded investors heavily, so the key issue is whether today’s price still leaves room for further upside. Expectations around earnings growth supported by capital returns, including buybacks, can support today’s valuation, while...
- ❖Jul 10, 10:10 PMnewsvia finnhub
McKesson (MCK) CEO Sells Shares As Company Names A New Strategy Chief
McKesson (NYSE:MCK) disclosed a significant insider sale by its CEO, executed under a pre arranged trading plan. The company also announced the retirement of a key executive and the immediate appointment of a new Chief Strategy Officer. These management moves come alongside an updated company outlook and revised growth targets. McKesson is a major healthcare services and distribution company that connects drug manufacturers, pharmacies, providers, and payers across the supply chain. Insider...
- ❖Jul 9, 6:47 PMnewsvia finnhub
McKesson (MCK) Stock Trades Down, Here Is Why
Shares of healthcare distributor and services company McKesson (NYSE:MCK) fell 3.5% in the afternoon session after reports revealed that CEO, Brian S. Tyler, sold 8,463 shares of company stock.
- ❖Jul 9, 3:05 PMnewsvia finnhub
Discover which S&P500 stocks are making waves on Thursday.
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Thursday.
- ❖Jul 9, 2:21 PMnewsvia finnhub
Should You Retain CAH Stock After Removal From Several Russell Indices?
CAH's Russell index removal reflects reclassification after its share rally, while specialty growth and resilient operations continue supporting its long-term outlook.
- ❖Jul 9, 12:35 PMnewsvia finnhub
Top S&P500 movers in Thursday's session
Curious about the S&P500 stocks that are in motion on Thursday? Join us as we explore the top movers within the S&P500 index during today's session.
- ❖Jul 9, 9:30 AMnewsvia finnhub
Brokers Suggest Investing in McKesson (MCK): Read This Before Placing a Bet
Based on the average brokerage recommendation (ABR), McKesson (MCK) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
- ❖Jul 9, 9:24 AMnewsvia finnhub
McKesson Stock Is Shrinking, and That's The Point for Owners
While the market debates growth, this healthcare giant is steadily retiring its own shares, a strategy that has quietly compounded value for investors.
- ❖Jul 9, 7:00 AMnewsvia finnhub
Congressional Trading Report: Rep. Ritchie Torres Bought Over $1K In McKesson Stock
July 8, 2026 records indicate that Representative Ritchie Torres filed a purchase of McKesson (NYSE:MCK), valued between $1,001 and $15,000. According to the July filing, the transaction occurred on January 7,
- ❖Jul 8, 2:24 PMnewsvia finnhub
McKesson Stock Is Shrinking, And That's The Point
While the market debates the future of drug pricing, this healthcare giant is steadily handing a larger piece of the business back to its owners.
- ❖Jul 8, 9:12 AMnewsvia finnhub
McKesson Checks All The Boxes To Survive And Prosper In A Weak Economy, But There's A Big Catch
McKesson is a stable portfolio holding with regular moderate growth amid a challenging, overvalued market environment. Read more on MCK stock here.
- ❖Jul 8, 9:00 AMnewsvia finnhub
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
- ❖Jul 7, 6:00 PMnewsvia finnhub
McKesson (MCK) Increases Despite Market Slip: Here's What You Need to Know
McKesson (MCK) closed the most recent trading day at $807.33, moving +2.95% from the previous trading session.
- ✓Jul 7, 9:45 AMdecisionacted
Agent 7 — Day Trader — decide: buy
MCK is up 6.17% intraday, a significant move representing real institutional flow. With 360 minutes remaining (effectively a full session still ahead), there is ample time for continuation. No headlines are available to explain the move, but absence of news does not disqualify momentum — large moves often precede or accompany institutional repositioning ahead of news or reflect block accumulation. The macro context (T10Y2Y at 2.1σ below trend, slightly flattening curve) is modestly relevant to defensives like MCK (healthcare/distribution), which can attract safe-haven flows in a flattening curve environment, providing a mild tailwind rather than headwind. The risk of a mean-reversion fade exists given the magnitude of the move (>6% is extended), and without a clear catalyst the setup is not high-conviction. However, the combination of strong momentum, defensive sector alignment with current macro, and ample time remaining tips the probability marginally above 0.5 for continuation. Sizing conservatively given the extended move and lack of fundamental catalyst.
- ▢Jul 6, 8:00 PMjournal
Agent 7 — Day Trader opened long 3 @ $802.04
- ▣Jul 6, 8:00 PMjournaltime_stop
Agent 7 — Day Trader closed long 3 @ $802.05 (+$0.04)
EOD forced close — day trader never carries overnight
- ❖Jul 6, 1:29 PMnewsvia finnhub
Eli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?
Growth premium vs. value recovery, one trades at 33x forward earnings while the other navigates debt reduction and biosimilar expansion.
- ❖Jul 6, 12:10 PMnewsvia finnhub
Will McKesson (MCK) Beat Estimates Again in Its Next Earnings Report?
McKesson (MCK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- ❖Jul 6, 10:30 AMnewsvia finnhub
[Latest] Global Healthcare Mobility Solutions Market Size/Share Worth USD 1411.37 Billion by 2035 at a 21.62% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)
[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Healthcare Mobility Solutions Market size & share revenue was valued at approximately USD 199.34 Billion in 2025 and is expected to reach USD 242.44 Billion in 2026 and is expected to reach around USD 1411.37 Billion by 2035, at a CAGR of 21.62% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are OMRON Healt
- ?Jul 2, 3:11 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MCK is up 2.16% today with no attributable headline, suggesting institutional flow or sector rotation rather than a news-driven catalyst. The macro context shows T10YIE at 1.6σ below trend, indicating compressed inflation expectations — MCK as a healthcare distributor is relatively insensitive to long-duration rate dynamics, so macro is neutral to slightly supportive (defensive positioning). With only 35 minutes remaining until the forced close, there is limited runway for further continuation; late-session momentum can persist but the time compression reduces the probability of a full extension. No reversal signal is evident (no fade mentioned), so baseline momentum bias holds. Assigning minimum continuation threshold — the move is real and uncontested by news or macro headwinds, but the short time window prevents a higher conviction read.
- !Jul 2, 3:11 PMsignalseverity 0.02
Agent 7 — Day Trader — day_trade_skipped
MCK is up 2.16% today with no attributable headline, suggesting institutional flow or sector rotation rather than a news-driven catalyst. The macro context shows T10YIE at 1.6σ below trend, indicating compressed inflation expectations — MCK as a healthcare distributor is relatively insensitive to long-duration rate dynamics, so macro is neutral to slightly supportive (defensive positioning). With only 35 minutes remaining until the forced close, there is limited runway for further continuation; late-session momentum can persist but the time compression reduces the probability of a full extension. No reversal signal is evident (no fade mentioned), so baseline momentum bias holds. Assigning minimum continuation threshold — the move is real and uncontested by news or macro headwinds, but the short time window prevents a higher conviction read.
- ?Jun 23, 10:35 AMdecisionconsidered
Agent 7 — Day Trader — analyze: fail
Claude analysis failed: Anthropic 529: {"type":"error","error":{"type":"overloaded_error","message":"Overloaded"},"request_id":"req_011CcLMj6GYJ3jt8QiD3XAxG"}
- !Jun 23, 10:35 AMsignal
Agent 7 — Day Trader — analyze_failed
- !Jun 11, 1:46 PMsignal
options_momentum — insufficient_capital
- !Jun 11, 1:33 PMsignal
options_momentum — insufficient_capital
- !Jun 11, 1:17 PMsignal
options_momentum — insufficient_capital
- !Jun 11, 12:46 PMsignal
options_momentum — insufficient_capital
- !Jun 11, 12:33 PMsignal
options_momentum — insufficient_capital
- !Jun 11, 12:17 PMsignal
options_momentum — insufficient_capital
- !Jun 11, 11:47 AMsignal
options_momentum — insufficient_capital
- !Jun 11, 11:34 AMsignal
options_momentum — insufficient_capital
- !Jun 11, 11:19 AMsignal
options_momentum — insufficient_capital
- !Jun 11, 10:47 AMsignal
options_momentum — insufficient_capital
- !Jun 11, 10:33 AMsignal
options_momentum — insufficient_capital
- !Jun 11, 10:18 AMsignal
options_momentum — insufficient_capital
- !Jun 11, 9:47 AMsignal
options_momentum — insufficient_capital
- !Jun 11, 9:34 AMsignal
options_momentum — insufficient_capital
- !Jun 11, 9:16 AMsignal
options_momentum — insufficient_capital
- !Jun 11, 9:05 AMsignal
options_momentum — insufficient_capital
- !Jun 11, 7:03 AMsignal
options_momentum — insufficient_capital
- ?Jun 5, 7:01 AMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $3.52 cash available; close=$756.95.
- ?Jun 5, 7:01 AMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
MCK (McKesson) is a large-cap healthcare distribution company with generally solid fundamentals; the 15% drop from the 30-day high lacks any visible fundamental catalyst (no news, no SEC filings, no insider activity in the window), suggesting the decline may be macro/sector-driven rather than company-specific impairment. However, the sector context is modestly negative (Health Care underperforming SPY by ~5.86pts over 30 days, today's sector flow proxy deeply negative), indicating MCK is caught in a broader sector-wide sell-off with limited near-term recovery catalysts. The options flow shows highly unusual put volume (z=5.58) on the most recent trading day with a near-parity P/C ratio, which is a meaningful caution signal even if some of it is hedging rather than directional bearishness.
- ?Jun 4, 6:04 PMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $0.53 cash available; close=$756.95.
- ?Jun 4, 6:03 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
MCK (McKesson) is a large-cap healthcare distribution company with generally solid fundamentals; the 15% drop from the 30-day high lacks any visible fundamental catalyst (no news, no SEC filings, no insider activity in the window), suggesting the decline may be macro/sector-driven rather than company-specific impairment. However, the sector context is modestly negative (Health Care underperforming SPY by ~5.86pts over 30 days, today's sector flow proxy deeply negative), indicating MCK is caught in a broader sector-wide sell-off with limited near-term recovery catalysts. The options flow shows highly unusual put volume (z=5.58) on the most recent trading day with a near-parity P/C ratio, which is a meaningful caution signal even if some of it is hedging rather than directional bearishness.
- ?Jun 4, 7:02 AMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
MCK (McKesson) is a large-cap healthcare distribution company with generally solid fundamentals; the 15% drop from the 30-day high lacks any visible fundamental catalyst (no news, no SEC filings, no insider activity in the window), suggesting the decline may be macro/sector-driven rather than company-specific impairment. However, the sector context is modestly negative (Health Care underperforming SPY by ~5.86pts over 30 days, today's sector flow proxy deeply negative), indicating MCK is caught in a broader sector-wide sell-off with limited near-term recovery catalysts. The options flow shows highly unusual put volume (z=5.58) on the most recent trading day with a near-parity P/C ratio, which is a meaningful caution signal even if some of it is hedging rather than directional bearishness.
- ?Jun 4, 7:02 AMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $2.80 cash available; close=$739.53.
- ?Jun 3, 6:06 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
MCK (McKesson) is a large-cap healthcare distribution company with generally solid fundamentals; the 15% drop from the 30-day high lacks any visible fundamental catalyst (no news, no SEC filings, no insider activity in the window), suggesting the decline may be macro/sector-driven rather than company-specific impairment. However, the sector context is modestly negative (Health Care underperforming SPY by ~5.86pts over 30 days, today's sector flow proxy deeply negative), indicating MCK is caught in a broader sector-wide sell-off with limited near-term recovery catalysts. The options flow shows highly unusual put volume (z=5.58) on the most recent trading day with a near-parity P/C ratio, which is a meaningful caution signal even if some of it is hedging rather than directional bearishness.
- ?Jun 3, 6:05 PMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $3.84 cash available; close=$739.95.
- ?Jun 3, 7:02 AMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $2.42 cash available; close=$736.78.
- ?Jun 3, 7:02 AMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
MCK (McKesson) is a large-cap healthcare distribution company with generally solid fundamentals; the 15% drop from the 30-day high lacks any visible fundamental catalyst (no news, no SEC filings, no insider activity in the window), suggesting the decline may be macro/sector-driven rather than company-specific impairment. However, the sector context is modestly negative (Health Care underperforming SPY by ~5.86pts over 30 days, today's sector flow proxy deeply negative), indicating MCK is caught in a broader sector-wide sell-off with limited near-term recovery catalysts. The options flow shows highly unusual put volume (z=5.58) on the most recent trading day with a near-parity P/C ratio, which is a meaningful caution signal even if some of it is hedging rather than directional bearishness.
- ?Jun 2, 6:04 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
MCK (McKesson) is a large-cap healthcare distribution company with generally solid fundamentals; the 15% drop from the 30-day high lacks any visible fundamental catalyst (no news, no SEC filings, no insider activity in the window), suggesting the decline may be macro/sector-driven rather than company-specific impairment. However, the sector context is modestly negative (Health Care underperforming SPY by ~5.86pts over 30 days, today's sector flow proxy deeply negative), indicating MCK is caught in a broader sector-wide sell-off with limited near-term recovery catalysts. The options flow shows highly unusual put volume (z=5.58) on the most recent trading day with a near-parity P/C ratio, which is a meaningful caution signal even if some of it is hedging rather than directional bearishness.
- ?Jun 2, 7:01 AMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $1.04 cash available; close=$734.82.
- ?Jun 2, 7:01 AMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
MCK (McKesson) is a large-cap healthcare distribution company with generally solid fundamentals; the 15% drop from the 30-day high lacks any visible fundamental catalyst (no news, no SEC filings, no insider activity in the window), suggesting the decline may be macro/sector-driven rather than company-specific impairment. However, the sector context is modestly negative (Health Care underperforming SPY by ~5.86pts over 30 days, today's sector flow proxy deeply negative), indicating MCK is caught in a broader sector-wide sell-off with limited near-term recovery catalysts. The options flow shows highly unusual put volume (z=5.58) on the most recent trading day with a near-parity P/C ratio, which is a meaningful caution signal even if some of it is hedging rather than directional bearishness.
- ?Jun 1, 6:04 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
MCK (McKesson) is a large-cap healthcare distribution company with generally solid fundamentals; the 15% drop from the 30-day high lacks any visible fundamental catalyst (no news, no SEC filings, no insider activity in the window), suggesting the decline may be macro/sector-driven rather than company-specific impairment. However, the sector context is modestly negative (Health Care underperforming SPY by ~5.86pts over 30 days, today's sector flow proxy deeply negative), indicating MCK is caught in a broader sector-wide sell-off with limited near-term recovery catalysts. The options flow shows highly unusual put volume (z=5.58) on the most recent trading day with a near-parity P/C ratio, which is a meaningful caution signal even if some of it is hedging rather than directional bearishness.
- ?Jun 1, 6:03 PMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $2.27 cash available; close=$735.70.
- ?Jun 1, 9:30 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MCK is down ~1.92% mid-session with 375 minutes (over 6 hours) remaining, suggesting this is early in the session with ample time for the move to continue or reverse. The move is meaningful but not extreme — it represents real selling pressure but hasn't reached the 2-5% threshold that would signal strong conviction. No headlines are available to explain the catalyst, which is neutral per guidance. The macro context (T10Y3M elevated at 1.6σ above trend) is flagged as relevant to Banks and recession-sensitive sectors; MCK is a healthcare distribution company, not directly in those sectors, so macro headwinds are modest and indirect at best. With no news driver, no clear reversal pattern described, and substantial time remaining, the base case is mild momentum continuation. However, the absence of a clear catalyst and the relatively modest decline (under 2%) leave this as a low-conviction setup. Assigning a slight lean toward continuation given the meaningful selling flow and ample time remaining, but probability stays near the floor given the weak evidence base.
- ?Jun 1, 7:03 AMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $29.62 cash available; close=$742.44.
- ?Jun 1, 7:02 AMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
MCK (McKesson) is a large-cap healthcare distribution company with generally solid fundamentals; the 15% drop from the 30-day high lacks any visible fundamental catalyst (no news, no SEC filings, no insider activity in the window), suggesting the decline may be macro/sector-driven rather than company-specific impairment. However, the sector context is modestly negative (Health Care underperforming SPY by ~5.86pts over 30 days, today's sector flow proxy deeply negative), indicating MCK is caught in a broader sector-wide sell-off with limited near-term recovery catalysts. The options flow shows highly unusual put volume (z=5.58) on the most recent trading day with a near-parity P/C ratio, which is a meaningful caution signal even if some of it is hedging rather than directional bearishness.
- ?May 29, 6:03 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip_no_cash
Wanted to buy but only $735.32 cash available; close=$742.94.
- ?May 29, 7:02 AMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $3.04 cash available; close=$756.98.
- ?May 29, 7:01 AMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip_no_cash
Wanted to buy but only $9.19 cash available; close=$756.98.
- ?May 28, 6:01 PMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $12.25 cash available; close=$756.47.
- ?May 28, 6:01 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip_no_cash
Wanted to buy but only $6.30 cash available; close=$756.47.
- ?May 28, 7:01 AMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $1.29 cash available; close=$756.47.
- ?May 28, 7:01 AMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip_no_cash
Wanted to buy but only $8.03 cash available; close=$756.47.
- ?May 27, 6:01 PMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $0.00 cash available; close=$754.40.
- ?May 27, 6:01 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip_no_cash
Wanted to buy but only $9.46 cash available; close=$754.40.
- ?May 27, 7:01 AMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $0.00 cash available; close=$754.40.
- ?May 27, 7:01 AMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip_no_cash
Wanted to buy but only $21.36 cash available; close=$754.40.
- ?May 26, 6:01 PMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $22.31 cash available; close=$766.08.
- ?May 26, 6:01 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip_no_cash
Wanted to buy but only $2.08 cash available; close=$766.08.
- ?May 26, 7:03 AMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $0.00 cash available; close=$766.08.
- ?May 26, 7:02 AMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip_no_cash
Wanted to buy but only $0.00 cash available; close=$766.08.
- ?May 22, 6:01 PMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $5.71 cash available; close=$766.50.
- ▢May 18, 8:00 PMjournal
Agent 4 — Dip Buyer (Frozen) opened long 1 @ $775.97